Clarity Medical Group Holding Limited (HKG:1406)
Hong Kong
· Delayed Price · Currency is HKD 0.3550
0.00 (0.00%)
At close: Jun 5, 2025, 4:00 PM HKT
HKG:1406 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Revenue | 176.52 | 190.93 | 213.85 | 225.24 | 222.38 | 218.38 | Upgrade
|
| Revenue Growth (YoY) | -15.04% | -10.71% | -5.06% | 1.28% | 1.83% | 5.70% | Upgrade
|
| Cost of Revenue | 95.36 | 101.3 | 93.09 | 83.03 | 75.52 | 84.82 | Upgrade
|
| Gross Profit | 81.16 | 89.64 | 120.76 | 142.21 | 146.86 | 133.56 | Upgrade
|
| Selling, General & Admin | 72.14 | 89.11 | 83.18 | 69.61 | 60.52 | 56.31 | Upgrade
|
| Other Operating Expenses | 20.08 | 19.37 | 20.39 | 15.02 | 13.3 | 14.02 | Upgrade
|
| Operating Expenses | 123.75 | 145.87 | 128.48 | 106.72 | 100.53 | 94.47 | Upgrade
|
| Operating Income | -42.58 | -56.23 | -7.72 | 35.49 | 46.33 | 39.09 | Upgrade
|
| Interest Expense | -1.45 | -2.02 | -1.53 | -0.78 | -0.9 | -1.12 | Upgrade
|
| Interest & Investment Income | 5.69 | 6.22 | 3.85 | 0.05 | 0 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.08 | - | - | - | - | -0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.08 | 0.18 | 0.32 | -17.24 | -8.56 | -4.77 | Upgrade
|
| EBT Excluding Unusual Items | -38.34 | -51.85 | -5.07 | 17.51 | 36.87 | 33.17 | Upgrade
|
| Asset Writedown | -37.35 | -30.05 | -0.15 | - | -0.09 | - | Upgrade
|
| Other Unusual Items | - | - | 2.3 | 1.53 | 7.03 | - | Upgrade
|
| Pretax Income | -76.27 | -81.9 | -2.92 | 19.05 | 43.82 | 33.17 | Upgrade
|
| Income Tax Expense | -1.93 | -6.1 | 0.27 | 5.56 | 8.05 | 6.78 | Upgrade
|
| Net Income | -74.34 | -75.79 | -3.19 | 13.49 | 35.77 | 26.39 | Upgrade
|
| Net Income to Common | -74.34 | -75.79 | -3.19 | 13.49 | 35.77 | 26.39 | Upgrade
|
| Net Income Growth | - | - | - | -62.28% | 35.55% | -12.16% | Upgrade
|
| Shares Outstanding (Basic) | 526 | 525 | 522 | 390 | 375 | 278 | Upgrade
|
| Shares Outstanding (Diluted) | 526 | 525 | 522 | 391 | 375 | 281 | Upgrade
|
| Shares Change (YoY) | 0.25% | 0.50% | 33.76% | 4.15% | 33.67% | 3.67% | Upgrade
|
| EPS (Basic) | -0.14 | -0.14 | -0.01 | 0.03 | 0.10 | 0.10 | Upgrade
|
| EPS (Diluted) | -0.14 | -0.14 | -0.01 | 0.03 | 0.10 | 0.09 | Upgrade
|
| EPS Growth | - | - | - | -63.61% | 0.96% | -15.22% | Upgrade
|
| Free Cash Flow | -16.17 | -48.39 | -13.98 | 27.35 | 62.17 | 35.46 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.09 | -0.03 | 0.07 | 0.17 | 0.13 | Upgrade
|
| Gross Margin | 45.98% | 46.95% | 56.47% | 63.14% | 66.04% | 61.16% | Upgrade
|
| Operating Margin | -24.12% | -29.45% | -3.61% | 15.75% | 20.83% | 17.90% | Upgrade
|
| Profit Margin | -42.12% | -39.70% | -1.49% | 5.99% | 16.09% | 12.08% | Upgrade
|
| Free Cash Flow Margin | -9.16% | -25.35% | -6.54% | 12.14% | 27.96% | 16.24% | Upgrade
|
| EBITDA | -27.13 | -40.34 | -1.54 | 43.19 | 54.7 | 45.89 | Upgrade
|
| EBITDA Margin | -15.37% | -21.13% | -0.72% | 19.18% | 24.60% | 21.02% | Upgrade
|
| D&A For EBITDA | 15.45 | 15.89 | 6.18 | 7.71 | 8.38 | 6.8 | Upgrade
|
| EBIT | -42.58 | -56.23 | -7.72 | 35.49 | 46.33 | 39.09 | Upgrade
|
| EBIT Margin | -24.12% | -29.45% | -3.61% | 15.75% | 20.83% | 17.90% | Upgrade
|
| Effective Tax Rate | - | - | - | 29.17% | 18.37% | 20.44% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.